Operating Lease, Liability, Noncurrent in USD of RIGEL PHARMACEUTICALS INC from Q1 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.
Summary
Rigel Pharmaceuticals Inc quarterly Operating Lease, Liability, Noncurrent history and change rate from Q1 2019 to Q3 2025.
  • Rigel Pharmaceuticals Inc Operating Lease, Liability, Noncurrent for the quarter ending September 30, 2025 was $556K.
Operating Lease, Liability, Noncurrent, Quarterly (USD)
Operating Lease, Liability, Noncurrent, YoY Quarterly Change (%)

RIGEL PHARMACEUTICALS INC Quarterly Operating Lease, Liability, Noncurrent (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $556K Sep 30, 2025 10-Q 2025-11-04
Q2 2025 $714K Jun 30, 2025 10-Q 2025-08-05
Q1 2025 $864K +$764K +764% Mar 31, 2025 10-Q 2025-05-06
Q1 2024 $100K -$702K -87.5% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $285K -$687K -70.7% Dec 31, 2023 10-K 2025-03-04
Q3 2023 $466K Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $628K Jun 30, 2023 10-Q 2023-08-01
Q1 2023 $802K Mar 31, 2023 10-Q 2023-05-02
Q4 2022 $972K +$213K +28.1% Dec 31, 2022 10-K 2024-03-05
Q4 2021 $759K -$9.89M -92.9% Dec 31, 2021 10-K 2023-03-07
Q3 2021 $3.31M -$9.62M -74.4% Sep 30, 2021 10-Q 2021-11-02
Q2 2021 $5.85M -$9.4M -61.6% Jun 30, 2021 10-Q 2021-08-03
Q1 2021 $8.3M -$9.01M -52.1% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 $10.7M -$8.58M -44.6% Dec 31, 2020 10-K 2022-03-01
Q3 2020 $12.9M -$8.25M -39% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $15.2M -$7.84M -33.9% Jun 30, 2020 10-Q 2020-08-04
Q1 2020 $17.3M -$7.65M -30.6% Mar 31, 2020 10-Q 2020-05-05
Q4 2019 $19.2M Dec 31, 2019 10-K 2021-03-02
Q3 2019 $21.2M Sep 30, 2019 10-Q 2019-11-05
Q2 2019 $23.1M Jun 30, 2019 10-Q 2019-08-06
Q1 2019 $25M Mar 31, 2019 10-Q 2019-05-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.